HKPD

Cellyan Biotechnology Co., LtdNASDAQHealthcare

$0.57-1.58%ClosedMarket Cap: $6.2M

As of 2026-04-06

Valuation

P/E (TTM)

4.80

PEG

—

P/B

1.01

P/S

0.30

EV/EBITDA

6.44

DCF Value

$0.39

FCF Yield

6.7%

Div Yield

0.0%

Margins & Returns

Gross Margin

11.9%

Operating Margin

0.7%

Net Margin

-0.1%

ROE

-0.6%

ROA

-0.3%

ROIC

-1.3%

Income Statement

Period	Revenue	Gross Margin	Operating Income	Net Income	EPS	Dividend
Q4 2025	$9.2M	5.5%	$-895.0K	$-855.6K	$-0.08	—
FY 2025	$20.3M	11.9%	$132.0K	$-27.1K	$-0.00	—
Q2 2025	$11.1M	17.2%	$1.0M	$828.6K	$0.08	—
Q4 2024	$9.7M	23.0%	$1.3M	$1.1M	$0.11	—
FY 2024	$16.7M	21.3%	$1.6M	$1.3M	$0.18	—
Q2 2024	$7.0M	19.1%	$308.8K	$249.0K	$0.04	—
FY 2023	$12.6M	21.8%	$1.0M	$998.2K	$0.09	—